NCT04069689View on ClinicalTrials.gov

Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

August 29, 2019

Primary Completion Date

November 27, 2019

Study Completion Date

November 27, 2019

Conditions

Dravet Syndrome

Interventions

DRUG

EPX-100 (Clemizole Hydrochloride)

EPX-100 (Clemizole Hydrochloride)

DRUG

Placebos

Placebo to match EPX-100

Trial Locations (1)

07410

TKL Research, Fair Lawn

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Epygenix

INDUSTRY